13F-HR: Globe Life Inc. Discloses Q1 2024 Holdings in Form 13F Filing

Globe Life Inc. reports its holdings as of March 31, 2024, in its Form 13F filing, revealing investments in Vanguard Scottsdale Funds and Vanguard Index Funds.

Summary

• Globe Life Inc. filed its Form 13F for the quarter ended March 31, 2024.
• The filing reports holdings in two Vanguard funds.
• The total value of the reported holdings is approximately $357.3 million.
• The holdings include 338,500 shares of Vanguard Scottsdale Funds, valued at approximately $26.5 million.
• The holdings also include 688,183 shares of Vanguard Index Funds, valued at approximately $330.8 million.
• Globe Life Inc. has sole voting authority over all the reported shares.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing, so the sentiment is neutral. It provides factual information about the company's holdings.

Positives

• The filing provides transparency into Globe Life Inc.'s investment holdings.
• The company maintains sole voting authority over its significant holdings in Vanguard funds.

Industry Context

Form 13F filings are a standard requirement for institutional investment managers with over $100 million in assets under management, providing transparency into their holdings and investment strategies. This filing allows investors to understand Globe Life's investment allocations within publicly traded securities.

Comparison to Industry Standards

• Form 13F filings are a standard practice for institutional investment managers like Globe Life Inc.
• The reported holdings are typical for insurance companies, which often invest in diversified index funds for long-term growth and stability.
• Comparable companies such as Prudential Financial or MetLife also file similar reports detailing their investment portfolios.

Stakeholder Impact

• Shareholders can gain insight into the company's investment strategy through this filing.
• The filing provides transparency to the market regarding Globe Life's investment portfolio.

Key Dates